Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Brain Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Nervous System Neoplasm
Central Nervous System Neoplasm
Intracranial Neoplasm
Brain Neoplasm

Subtype

Brain Neoplasm

CI-CAN-00002030Explore in graph →

Non-malignant511 active trials34 evidence items

NCIt: C2907
MeSH: D001932

Overview
Statistics
Survival
Genomics7
Variants & evidence34
Drugs5
Trials2117
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (33)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 33 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
· Acta Neuropathol · 2016 · PMID 27157931 · validated civic_curation pubmed
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
· Lancet Oncol · 2017 · PMID 28545823 · validated civic_curation pubmed
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
· Cancer Cell · 2014 · PMID 24651015 · validated civic_curation pubmed
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
· Cell Cycle · 2006 · PMID 17172831 · validated civic_curation pubmed
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
· Cell · 2016 · PMID 26919435 · validated civic_curation pubmed
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
· Cancer Cell · 2015 · PMID 25965575 · validated civic_curation pubmed
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
· Acta Neuropathol Commun · 2021 · PMID 33536079 · validated

Showing 1–25 of 33 publications

← Previous
1
2
Next →

civic_curation

Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.

· Brain Pathol · 2019 · PMID 30246434 · validated civic_curation pubmed

Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.

· Clin Epigenetics · 2023 · PMID 36895035 · validated civic_curation pubmed

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

· Cancer Res · 2003 · PMID 14583498 · validated civic_curation pubmed

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.

· Nat Genet · 2012 · PMID 22286216 · validated civic_curation pubmed

Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.

· J Pathol · 2009 · PMID 19197950 · validated civic_curation pubmed

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.

· Nature · 2014 · PMID 24553141 · validated civic_curation pubmed

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma.

· Neurooncol Adv · 2023 · PMID 37287693 · validated civic_curation pubmed

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.

· Neuro Oncol · 2019 · PMID 30976811 · validated civic_curation pubmed

Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.

· Acta Neuropathol · 2014 · PMID 24562983 · validated civic_curation pubmed

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

· J Clin Oncol · 2015 · PMID 26169613 · validated civic_curation pubmed

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.

· Science · 2009 · PMID 19726788 · validated civic_curation pubmed

Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.

· JCO Precis Oncol · 2024 · PMID 38603650 · validated civic_curation pubmed

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.

· Acta Neuropathol Commun · 2021 · PMID 34389065 · validated civic_curation pubmed

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

· Mod Pathol · 2020 · PMID 31375766 · validated civic_curation pubmed

Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.

· J Neuropathol Exp Neurol · 2021 · PMID 34363682 · validated civic_curation pubmed

Supratentorial ependymoma with YAP1:FAM118B fusion: A case report.

· Neuropathology · 2021 · PMID 33480048 · validated civic_curation pubmed

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.

· Neurooncol Adv · 2022 · PMID 35673607 · validated civic_curation pubmed

A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.

· Cell Rep · 2018 · PMID 29949764 · validated civic_curation pubmed